These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4369866)

  • 1. Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia.
    Carvalho AC; Colman RW; Lees RS
    Circulation; 1974 Sep; 50(3):570-4. PubMed ID: 4369866
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet function in hyperlipoproteinemia.
    Carvalho AC; Colman RW; Lees RS
    N Engl J Med; 1974 Feb; 290(8):434-8. PubMed ID: 4359434
    [No Abstract]   [Full Text] [Related]  

  • 3. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function in thrombosis and atherosclerosis.
    Colman RW
    Adv Exp Med Biol; 1978; 104():421-36. PubMed ID: 213955
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
    Lin CY; Smith S
    Life Sci; 1976 Mar; 18(6):563-8. PubMed ID: 1263738
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of clofibrate and 6-substituted chroman analogs on human platelet function: mechanism of inhibitory action.
    Huzoor-Akbar ; Patel S; Kokrady SS; Witiak DT; Newman HA; Feller DR
    Biochem Pharmacol; 1981 Jul; 30(14):2013-20. PubMed ID: 7271890
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet function in hyperbetalipoproteinemia.
    Colman RW
    Thromb Haemost; 1978 Apr; 39(2):284-93. PubMed ID: 580982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA; Penttilä IM; Lampainen E
    Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy.
    Harker LA; Hazzard W
    Circulation; 1979 Sep; 60(3):492-6. PubMed ID: 455611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet hypersensitivity induced by cholesterol incorporation.
    Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
    J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet hypersensitivity and intravascular coagulation in paroxysmal nocturnal hemoglobinuria.
    Steinberg D; Carvalho AC; Chesney CM; Colman RW
    Am J Med; 1975 Dec; 59(6):845-50. PubMed ID: 1190256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of halothane on platelet function.
    Dalsgaard-Nielsen J; Gormsen J
    Thromb Haemost; 1980 Dec; 44(3):143-5. PubMed ID: 7466741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unorthodox reflections about arteriosclerosis].
    Kaunitz H
    Wien Klin Wochenschr; 1970 Nov; 82(46):825-8. PubMed ID: 5521420
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of nonresponsiveness to epinephrine in platelets from healthy humans.
    Choi JW
    Acta Haematol; 2002; 108(2):106-8. PubMed ID: 12187031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

  • 19. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.